Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Jazz Pharmaceuticals plc
| Okres |
2023-12-31 |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
3,843.38 |
4,051.37 |
4,356.63 |
4,572.34 |
4,755.99 |
5,016.25 |
| Przychód Δ r/r |
0.00% |
5.41% |
7.53% |
4.95% |
4.02% |
5.47% |
| Przychód (min) |
3,793.20 |
4,001.36 |
4,128.38 |
4,384.38 |
4,560.48 |
4,810.05 |
| Przychód (max) |
3,943.72 |
4,111.39 |
4,614.66 |
4,760.27 |
4,951.46 |
5,222.42 |
| EBITDA (średnia) |
1,068.02 |
1,427.83 |
1,535.41 |
1,611.44 |
1,676.16 |
1,767.88 |
| EBIT (średnia) |
464.08 |
759.30 |
816.51 |
856.94 |
891.36 |
940.14 |
| EBIT % |
12.07% |
18.74% |
18.74% |
18.74% |
18.74% |
18.74% |
| Zysk netto (średni) |
330.79 |
1,336.38 |
596.91 |
632.03 |
1,706.84 |
1,835.83 |
| Zysk netto % |
8.61% |
32.99% |
13.70% |
13.82% |
35.89% |
36.60% |
| EPS (średnia) |
5.25 |
18.54 |
8.55 |
8.63 |
23.68 |
25.47 |
| Liczba analityków (Przychody) |
15 |
14 |
15 |
15 |
7 |
6 |
| Liczba analityków (EPS) |
10 |
13 |
12 |
4 |
1 |
2 |
| symbol |
JAZZ |
JAZZ |
JAZZ |
JAZZ |
JAZZ |
JAZZ |